Dupilumab facial redness: Clinical characteristics and proposed treatment in a cohort
DERMATOLOGIC THERAPY（2021）
Abstract
In this case series, we report for the first time in the literature in a cohort, the positive response to oral or topical antifungals for atopic dermatitis patients treated with Dupilumab that developed Dupilumab facial redness, supporting the Malassezia hypersensitivity theory.
MoreTranslated text
Key words
adverse effects, atopic dermatitis, Dupilumab, facial redness, head and neck dermatitis, Malassezia
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined